AXIL Brands Announces Participation in the 38th Annual ROTH Conference March 22–24, 2026
Rhea-AI Summary
AXIL Brands (NYSE American: AXIL) will participate in the 38th Annual ROTH Conference March 22–24, 2026 at The Ritz-Carlton Laguna Niguel in Dana Point, California.
CEO Jeff Toghraie and CFO Jeff Brown will hold one-on-one and small group meetings to discuss growth initiatives, hearing protection portfolio scaling, retail expansions, and product innovations. Attendees can request meetings via Roth representatives or the conference portal.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
AXIL fell 4.37% while peers showed mixed moves: KOSS up 1.71%, RIME up 4.76%, and FEBO, UEIC, WLDS down modestly. Only WLDS appeared on the momentum scanner, moving up over 5%, indicating AXIL’s action was more stock-specific than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 08 | Earnings results | Positive | +15.6% | Profitable 2Q26 results with higher net sales and net income. |
| Dec 18 | Product launch | Positive | -1.2% | Launch of MX II earmuffs using SonicShieldX platform and new variants. |
| Dec 11 | Retail expansion | Positive | +59.4% | National Walmart distribution agreement for X30 LT hearing protection. |
| Oct 30 | Product launch | Positive | +6.8% | Launch of GS Extreme 3.0 tactical earbuds with upgraded specs. |
| Oct 07 | Earnings results | Positive | +4.3% | 1Q26 results showing double-digit net sales growth and return to profit. |
AXIL has generally reacted positively to operational and earnings updates, with only one recent product launch seeing a modest negative reaction.
Over the past six months, AXIL reported profitable growth in 1Q26 and 2Q26, with net sales reaching $6.9M and then $8.1M and margins near the high-60% range. Earnings releases on Oct 7, 2025 and Jan 8, 2026 were followed by gains of 4.25% and 15.56%. Strategic product and retail milestones, including GS Extreme 3.0, MX II earmuffs, and a Walmart nationwide rollout to 3,700+ stores, also saw strong reactions, particularly the Walmart deal with a 59.36% move, framing today’s conference appearance within an ongoing growth and distribution push.
Market Pulse Summary
This announcement highlights AXIL’s participation in a major investor conference, positioning management to discuss growth initiatives and its role in the hearing protection category. In context, recent quarters showed profitable growth and new big-box retail placements alongside multiple product launches. Investors following the story may watch how conference meetings reinforce themes from prior earnings and distribution updates, and how the company builds on momentum in both its hearing and hair/skin care portfolios.
AI-generated analysis. Not financial advice.
LOS ANGELES, March 04, 2026 (GLOBE NEWSWIRE) -- AXIL Brands, Inc. (“AXIL” or the “Company”) (NYSE American: AXIL), an emerging global consumer products company offering AXIL® hearing protection and enhancement products alongside Reviv3® premium hair and skin care solutions, today announced that its management team will participate in the 38th Annual ROTH Conference, hosted by Roth Capital Partners.
The conference will take place March 22–24, 2026, at The Ritz-Carlton Laguna Niguel in Dana Point, California.
Jeff Toghraie, AXIL’s Chief Executive Officer, and Jeff Brown, AXIL’s Chief Financial Officer, will be available for one-on-one and small group meetings throughout the event. Discussions will focus on the Company’s exciting growth initiatives, including its emergence as a profitable leader in the hearing protection category.
Conference attendees are encouraged to request meetings with management through their Roth representatives or via the online conference portal.
This participation underscores AXIL’s momentum in scaling its hearing protection portfolio amid key retail expansions and product innovations.
For more information on the 38th Annual ROTH Conference, visit roth.com/conferences. Qualified participants can access registration and scheduling details there.
About AXIL Brands
AXIL Brands (NYSE American: AXIL) is an emerging global consumer products company. The Company is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, under the AXIL® brand and premium hair and skincare products under its in-house Reviv3® brand - selling products in the United States, Canada, the European Union, and throughout Asia.
To learn more, please visit the Company's AXIL® website at www.axilbrands.com and its Reviv3® website at www.reviv3.com
Forward-Looking Statements
This press release contains a number of forward-looking statements within the meaning of the federal securities laws. The use of words such as “anticipate,” “believe,” “expect,” “continue,” “will,” “may,” “prepare,” “should,” and “focus,” among others, generally identify forward-looking statements. These forward-looking statements are based on currently available information, and management’s beliefs, projections, and current expectations, and are subject to a number of significant risks and uncertainties, many of which are beyond management’s control and may cause the Company’s results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: (i) the Company’s ability to grow its net sales and operations, including developing new and improved products, diversifying and expanding its distribution and retail channels, and expanding internationally, and perform in accordance with any guidance; (ii) the Company’s ability to generate sufficient revenue to support the Company’s operations and to raise additional funds or obtain other forms of financing as needed on acceptable terms, or at all; (iii) potential difficulties or delays the Company may experience in implementing its cost savings and efficiency initiatives; (iv) the Company’s ability to compete effectively with other hair and skincare companies and hearing enhancement and protection companies; (v) the concentration of the Company’s customers, potentially increasing the negative impact to the Company by changing purchasing or selling patterns; (vi) changes in laws or regulations in the United States and/or in other major markets, such as China, in which the Company operates, including, without limitation, with respect to taxes, tariffs, trade policies or product safety, which may increase the Company’s product costs and other costs of doing business, and reduce the Company’s earnings; (vii) the Company’s ability to engage in acquisitions, investments, partnerships, strategic alliances or dispositions when desired; (viii) the Company’s ability to successfully accelerate its supply chain transition strategy and achieve the intended benefits; and (ix) the impact of unstable market and general economic conditions on the Company’s business, financial condition and stock price, including inflationary cost pressures, the possibility of an economic recession and other macroeconomic factors, geopolitical events, and uncertainty, increased tariffs and other trade restrictions and barriers, unemployment rates, decreased discretionary consumer spending, supply chain disruptions and constraints, labor shortages, ongoing economic disruption, including the effects of the U.S. federal government shutdown, the Ukraine-Russia conflict and conflict in the Middle East, and other downturns in the business cycle or the economy. There can be no assurance as to any of these matters, and potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. Other important factors that may cause actual results to differ materially from those expressed in the forward-looking statements are discussed in the Company’s filings with the U.S. Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.
Investor Relations:
FAQ
When will AXIL (AXIL) participate in the 38th Annual ROTH Conference?
Who from AXIL (AXIL) will attend the ROTH Conference on March 22–24, 2026?
How can investors schedule meetings with AXIL management at the ROTH Conference 2026?
What topics will AXIL (AXIL) discuss at the 38th Annual ROTH Conference March 22–24, 2026?
Does AXIL (AXIL) expect to present a formal corporate presentation at the ROTH Conference 2026?
Where can qualified participants find registration and scheduling details for AXIL meetings at ROTH Conference 2026?
